https://doi.org/10.1038/ncomms9839
V
Vicente Peg
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
244
Papers
6.0K
Citations
37
h-index
64
i10-index
Vicente Peg is an academic researcher from Hebron University. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Genomics and Diagnostics & HER2/EGFR in Cancer Research. The author has an h-index of 37, co-authored 208 publications.
ORCID: 0000-0002-5203-6166Papers by this author
worksCerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
2015 · Nature Communications · 822 citations
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
2014 · Annals of Oncology · 373 citations
https://doi.org/10.1093/annonc/mdu239
MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients
2015 · Oncotarget · 150 citations
https://doi.org/10.18632/oncotarget.5495
Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer
2016 · Oncotarget · 116 citations
https://doi.org/10.18632/oncotarget.10787
High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti‐HER2 therapy
2015 · Molecular Oncology · 88 citations
https://doi.org/10.1016/j.molonc.2015.09.002
p95HER2–T cell bispecific antibody for breast cancer treatment
2018 · Science Translational Medicine · 76 citations
https://doi.org/10.1126/scitranslmed.aat1445
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat